Introduction
Carotid artery stenting (CAS) has developed rapidly over the last decade as a minimally invasive alternative to carotid endarterectomy (CEA) for extracranial carotid artery stenosis [1] [2] [3] [4] . Acute or subacute in-stent thrombosis is a rare but potentially devastating complication following CAS [5] [6] [7] . We experienced the patient who had major stroke because of subacute in-stent thrombosis one week after CAS in early chronological series before 2004. We perform follow-up CT angiography at 7-10 days after CAS. Asymptomatic small in-stent low density areas supposed plaque protrusion or thrombus are sometimes observed on CT angiography after CAS. However, there is no report regarding these small in-stent low density areas after CAS to our knowledge. We investigate the frequency and time course of small instent low density areas after carotid artery stenting and discuss their nature and clinical significance.
Materials and Method
Between May 2005 to November 2007, 23 CASs were performed for 20 patients (16 males and 4 females, mean age 72.1 years, ranged 60-80) with cervical carotid artery stenosis.
Summary
Carotid stenting (CAS) for carotid stenosis has developed rapidly over the last decade. Instent low density area supposed plaque protrusion or thrombus is sometimes observed on CT angiography after CAS. We evaluate the frequency and time course of the small in-stent low density after carotid artery stenting and discuss its nature and clinical significance.
Between May 2005 to November 2007, 23 CASs were performed for 20 patients with carotid artery stenosis. All patients had no instent defect on digital subtraction angiography (DSA) immediately after the procedure. Followup CT angiography was performed at seven 7-10 days, 1-2 months, 6 months, and then every 6 months following CAS. We retrospectively reviewed the follow-up CT angiographic findings and clinical ischemic events.
Small in-stent low density areas on CT angiography were observed in 6 lesions (26%). Four cases were added warfarin to antiplatlets and the other two cases had antiplatlets only. The in-stent low density areas were disappeared within four months after CAS and no ischemic event was observed in five patients.
In the other patient, a small in-stent low density area had decreased at one month after CAS, but another small in-stent low density area appeared at five months.
Subacute small in-stent low density areas were frequently observed on CT angiography follow-Two cases (case 7 and 16) were performed CAS for bilateral carotid stenosis and one (case 11) were performed CAS for primary stenosis and re-stenosis.
All patients were given antiplatlets [aspirin (100 mg) and tichropidine (200 mg), cilostazol (200 mg), or clopidogrel (75 mg)] beginning at least three days before the intervention. Three cases were given warfarin added to the antiplatlets because of transient ischemic attack or chronic atrial fibrillation. Techniques of CAS, including the protection device, size and kinds of stents and angioplasty balloon, were mainly planned based on findings of cervical and intracranial CT angiography.
All CAS procedures were performed by transfemoral approach with local anesthesia.
Intravenous heparin was given to maintain an activated clotting time around 300 sec. throughout the procedure. A 6F, 90cm shuttle sheath (Cook, Bloomington, USA) was placed in the distal common carotid artery (CCA) with a coaxial system using 4F JB2 catheter. Guardwire (Medtronics, Inc, USA) embolic protection device was used in 18 patients. Filterwire (Mintcatch; Century medical, Inc, Tokyo, Japan) was used for some five patients who were guessed to be intolerable for temporary internal carotid arterial occlusion. A 0.014-inch guidewire system with protection balloon or filter was manipulated to cross the carotid stenosis. After the activation of the embolic protection devices, a monorail angioplasty balloon with 3-3.5 mm diameter balloon was used to predilate the carotid lesion if necessary. Next, a self expandable stent (SMARTer, Precise [Johnson & Johnson, USA] or Wallstent RP [Boston Scientific, USA]) was deployed across the carotid stenosis. Poststenting balloon angioplasty was performed with monorail angioplasty balloon of the almost same size of just distal internal carotid artery from stenotic lesion.
All cases had no in-stent defect on DSA immediately after the procedure.
Follow-up CT angiography was performed at 7-10 days, 1-2 months, 6 month, and then every six months following CAS. If in-stent low density area remained on follow-up CT 2 months after CAS, additional follow-up CT was performed at 4 month after CAS.
We retrospectively reviewed the follow-up CT angiographic findings and clinical ischemic events. Factors potentially affecting the occurrence of in-stent low density area, including ulcerated lesion before CAS, hypoechoic plaque, and stent types (open cell design or closed cell design) were also assessed. A Yates 2x2 Chi square test was performed. Test results were considered significant at a P<0.05.
Results
Imaging findings before the procedure and technical details are summarized in Table 1 . No neurological complication was observed during the procedures and perioperative periods.
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Small in-stent low density areas were observed in 6 lesions (26%) on the initial followup CT angiography. Factors potentially affecting the development of in-stent low density areas are summarized in Table 2 .
In the following factors, symptomatic lesion, coexistence of diabetes mellitus and techniques of CAS including stent design, and use of pre/post balloon dilatation, there were no differences in frequency between the 6 cases developing in-stent low density areas (in-stent low density group) and the other cases without in-stent low density areas. The other factors, including coexistence of ischemic heart disease and hyperlipidemia, presence of ulcerated lesion, and hypoechoic plaque, were more fre- On a lateral view of a right carotid arteiogram (C) immediately after CAS, no in stent filling defect is seen. On CTA (D,E) 7 days after CAS, small in-stent low density area is seen. This patient was observed with antiplatelets only. The small low density area decreased on CTA one month after CAS, and disappeared on CTA three months after CAS.
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quently seen in the in-stent low density group. However, there were no statistical significant differences between the both groups.
Ulceration had been observed in 4 (66.7%) of 6 cases developing in-stent low density area on preprocedural CT. On the other hand, it was found in 4 (23.5%) of 17 cases without in-stent low density. Four cases in small in-stent low density areas group were able to be assessed by carotid utlrasonography, and three of four cases (75%) had hypoechoic plaque (soft plaque).
Of the lesions without in-stent low density area, 13 cases were able to be assessed by carotid utlrasonography, and three (23%) had hypoechoic plaque. Six lesions couldn't be sufficiently assessed because of severe long segment stenosis and/or marked calcification.
Four cases were added warfarin to antiplatlets and other two cases ( Figure 1 ) had antiplatlets only. No ischemic event was observed in the 6 patients during 7-23 months follow-up periods (mean 19.6). The in-stent low density areas were disappeared within four months after CAS. In the other one patient, small in-stent low density area was decreased at 1 month after CAS, but another small instent low density area was appeared at five months.
Discussion
CEA is the gold standard treatment for patient with high-grade carotid artery stenosis and its efficacy has been clearly documented in numerous previous reports [8] [9] [10] [11] [12] . However, it has been reported that CAS with distal protection device performed similarly to the CEA for a limited group of CEA high-risk patients 2, [13] [14] [15] . Because of its less invasiveness and high success rates, CAS has become an alternative to CEA for this subgroup.
Complications of CAS include intraoperative distal embolic event, arterial dissection, carotid sinus reaction, delayed embolism and hyperperfusion syndrome. Acute/subacute instent occlusion/stenosis resulting from plaque protrusion and thrombus is a rare but serious complication following CAS.
Asymptomatic small in-stent low density areas are sometimes observed on early follow-up CT angiography after CAS. In this study, small in-stent low density areas were observed in six lesions (26%). The in-stent low density areas would probably had represented a small plaque protrusion or an in-stent thrombus; however, it is difficult to identify whether it is plaque protrusion or thrombus.
In the coronary interventions, many reports of pathological changes after angioplasty or stenting have been published 16, 17 . Early after stenting, fibrin, platelets, and acute inflammatory cells are nearly always present in association with stent struts. Plaque is compressed by the stent struts, and penetration of the stent struts into a lipid core is commonly observed 16 . In the present study, four of six lesions developing small in-stent low density areas that showed ulceration before CAS, and three of four lesions had hypoechoic plaque supposed lipid rich plaque. Although there is no statistical significance, the ulcerated and/or hypoechoic lesions were more frequently seen in cases developing small in-stent low density areas.
In cases using open cell design stents, CT showed small round in-stent low density area protruded through the open area between the struts. It was assumed that small in-stent low density area consist mainly of plaque protrusion. In carotid artery stenting, a self-expandable stent is used.
Clark et Al, using serial intravascular ultrasound imaging, reported that self-expandable stents deployed in carotid arteries continue to 18 . Soft plaque may protrude into the stent a few days after CAS, even if no plaque protrusion has been observed immediately after CAS. Plaque protrusion seems to occur less frequently with closed cell design stents rather than the open cell design stents. However in our study, small in-stent low density areas were observed in two lesions used closed cell design stents (Wallstent RP). This would suggest that the mesh of all stents currently in use cannot completely push out the soft plaque. In most cases, these small low density areas were disappeared by medication (antiplatelets and anticoagulant). However, it is supposed that relatively large amount of plaque protrusion into the stent can cause thrombus formation and subacute in-stent thrombosis. Any small low density area should be carefully followed up with warfarin added to antiplatelets. Minute low density area may disappear by antiplatelets only.
Conclusions
Subacute small in-stent low density areas were frequently observed on CT angiography following CAS. The small low density areas will disappear without clinical events by medication in most case.
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